Late recurrence of a primitive neuro-ectodermal tumor

Oncology

Volumn 61, Issue 3, 2001, Pages 189-191

  Rao, Ravi D ^a   Robins, H Ian ^a,b   Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Collin's law; Medulloblastoma; Primitive neuro ectodermal tumor; Temozolomide

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER TISSUE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; NEUROECTODERM TUMOR; PINEAL BODY TUMOR; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

ADULT; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS, ALKYLATING; CEREBELLAR NEOPLASMS; CERVICAL VERTEBRAE; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DURA MATER; FEMALE; HUMANS; ISOENZYMES; LUMBOSACRAL REGION; MENINGEAL NEOPLASMS; NEOPLASM PROTEINS; NEUROECTODERMAL TUMORS, PRIMITIVE; PHOSPHOPYRUVATE HYDRATASE; PINEALOMA; RADIOSURGERY; REMISSION INDUCTION; SCIATICA; SPINAL NEOPLASMS; SYNAPTOPHYSIN; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 0035742386     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055373     Document Type: Article

References (9)

1. The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: A phase III study in a high-risk patient population
2. Recurrence of medulloblastoma 19 years after the initial diagnosis
3. Recurrence of medulloblastoma: Violation of Collins' law after two decades
4. Late recurrence in medulloblastoma
5. Medulloblastoma and Collins' law: A critical review of the concept of a period of risk for tumor recurrence and patient survival
6. The applicability of Collins' law to childhood brain tumors and its usefulness as a predictor of survival
7. Collins' law: Prediction of recurrence or cure in childhood medulloblastoma?
8. Risk factors of recurrence in 157 MB/PNET patients treated in one institution
9. Late recurrences of histiocytic lymphoma after treatment